Drostanolone
Clinical data | |
---|---|
Trade names | Drolban, Masteril, Masteron, others (all as drostanolone propionate) |
Other names | Dromostanolone; 2α-Methyl-4,5α-dihydrotestosterone; 2α-Methyl-DHT; 2α-Methyl-5α-androstan-17β-ol-3-one |
Routes of administration | Intramuscular injection (as drostanolone propionate) |
Drug class | Androgen; Anabolic steroid |
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Drostanolone, or dromostanolone, is an
Pharmacology
Pharmacodynamics
Medication | Ratioa |
---|---|
Testosterone | ~1:1 |
Androstanolone (DHT) | ~1:1 |
Methyltestosterone | ~1:1 |
Methandriol | ~1:1 |
Fluoxymesterone | 1:1–1:15 |
Metandienone | 1:1–1:8 |
Drostanolone | 1:3–1:4 |
Metenolone | 1:2–1:30 |
Oxymetholone | 1:2–1:9 |
Oxandrolone | 1:3–1:13 |
Stanozolol | 1:1–1:30 |
Nandrolone | 1:3–1:16 |
Ethylestrenol | 1:2–1:19 |
Norethandrolone | 1:1–1:20 |
Notes: In rodents. Footnotes: a = Ratio of androgenic to anabolic activity. Sources: See template. |
Like other AAS, drostanolone is an
Chemistry
Drostanolone, also known as 2α-methyl-5α-dihydrotestosterone (2α-methyl-DHT) or as 2α-methyl-5α-androstan-17β-ol-3-one, is a
History
Drostanolone and its ester drostanolone propionate were first described in 1959.[4][6] Drostanolone propionate was first introduced for medical use in 1961.[7]
Society and culture
Generic names
Drostanolone is the
,Legal status
Drostanolone, along with other AAS, is a schedule III controlled substance in the United States under the Controlled Substances Act.[8]
Potential side effects
Like other AAS, drostanolone can cause a variety of side effects, including:
- Virilization: This refers to the development of masculine characteristics in women, such as deepening of the voice, increased body hair growth, and clitoral enlargement.
- Acne: AAS can increase sebum production, leading to acne.
- Hair loss: Drostanolone can accelerate male pattern baldness.
- Cardiovascular issues: AAS can negatively affect cholesterol levels and increase the risk of cardiovascular disease.
- Liver damage: Although drostanolone is not 17α-alkylated, high doses or prolonged use can still potentially damage the liver.
- Mood swings: AAS can cause aggression, irritability, and mood swings.
Non-medical uses
Drostanolone is used by some bodybuilders and athletes to increase muscle mass and strength. It is often used during "cutting cycles" to help preserve muscle mass while losing body fat. However, the use of AAS for non-medical purposes is not recommended due to the potential for serious side effects.
Synthesis
Bolazine is when react 2 eq. with hydrazine to give dimer
Treatment of DHT (androstan-17β-ol-3-one, stanolone) [521-18-6] (1) with methyl formate and the strong base sodium methoxide gives [4033-95-8] (2). The newly added formyl function in the product is shown in the enol form. Catalytic hydrogenation reduces that function to a methyl group (3). The addition of hydrogen from the bottom face of the molecule leads to the formation of β-methyl isomer where the methyl group occupies the higher-energy axial position. Strong base-induced equilibration of the methyl group leads to the formation of the sterically favoured equatorial α-methyl isomer, affording dromostanolone (4).
References
- ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-15.
- ^ ISBN 978-1-4757-2085-3.
- ^ ISBN 978-3-88763-075-1.
- ^ ISBN 978-0-9828280-1-4.
- PMID 1242823.
- ISSN 0002-7863.
- ISBN 978-0-8155-1856-3.
- ISBN 978-1-4200-0346-8.
- .
- ^ Volovel'skii, L.N. et al, Zh. Obschch. Khim., 1966, 46, 1772.
- ^ US 2908693, Ringold HJ, Rosenkranz G, issued 1959, assigned to Syntex SA
- ^ US 3118915, Ringold HJ, Rosenkranz G, issued 1964, assigned to Roche Palo Alto LLC
- ^ GB 1005896 US 3249627, issued 1966, assigned to Ormonoterapia Richter Spa